The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients

J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2023.01.014. Epub 2023 Jan 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / adverse effects
  • COVID-19 Drug Treatment
  • COVID-19*
  • Epilepsy* / drug therapy
  • Epilepsy* / epidemiology
  • Humans
  • Retrospective Studies
  • Ritonavir / adverse effects
  • Seizures / drug therapy
  • Seizures / epidemiology

Substances

  • nirmatrelvir
  • Ritonavir
  • Antiviral Agents